These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23585862)

  • 1. Early detection of NSCLC with scFv selected against IgM autoantibody.
    Pedchenko T; Mernaugh R; Parekh D; Li M; Massion PP
    PLoS One; 2013; 8(4):e60934. PubMed ID: 23585862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
    Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
    Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
    Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.
    Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
    Front Immunol; 2021; 12():728853. PubMed ID: 35140701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer.
    Farlow EC; Patel K; Basu S; Lee BS; Kim AW; Coon JS; Faber LP; Bonomi P; Liptay MJ; Borgia JA
    Clin Cancer Res; 2010 Jul; 16(13):3452-62. PubMed ID: 20570928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
    Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic efficiency of seven autoantibodies in lung cancer.
    Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
    Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
    Zhang C; Ye L; Guan S; Jin S; Wang W; Sun S; Lee KH; Wei J; Liu B
    Tumour Biol; 2014 Mar; 35(3):2047-51. PubMed ID: 24122232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis.
    Yao Y; Fan Y; Wu J; Wan H; Wang J; Lam S; Lam WL; Girard L; Gazdar AF; Wu Z; Zhou Q
    Biochem Biophys Res Commun; 2012 Jul; 423(3):613-9. PubMed ID: 22713465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer.
    Khattar NH; Coe-Atkinson SP; Stromberg AJ; Jett JR; Hirschowitz EA
    Cancer Biol Ther; 2010 Aug; 10(3):267-72. PubMed ID: 20543565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.
    Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L
    Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Autoantibody Against Human DNA-Topoisomerase I Is a Novel Biomarker for Non-Small Cell Lung Cancer.
    Wu WB; Yie SM; Ye SR; Xie K; Zhang JB; Cao M; Chen J; He X; Ma XL; Zhang J
    Ann Thorac Surg; 2018 Jun; 105(6):1664-1670. PubMed ID: 29453962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rethinking Autoantibody Signature Panels for Cancer Diagnosis.
    Campa MJ; Gottlin EB; Herndon JE; Patz EF
    J Thorac Oncol; 2017 Jun; 12(6):1011-1014. PubMed ID: 28126538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
    Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
    J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer.
    Sun N; Chen Z; Tan F; Zhang B; Yao R; Zhou C; Li J; Gao Y; Liu Z; Tan X; Zhou F; He MY; Shao K; Li N; Qiu B; Sun J; Yu Y; Wang S; Zhao Y; Shi X; He J
    Clin Cancer Res; 2013 Sep; 19(18):5136-45. PubMed ID: 24046070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.